Cinnarizine has an atypical antipsychotic profile in animal models of psychosis

Journal of Psychopharmacology

Volumn 19, Issue 4, 2005, Pages 342-346

  Dall'Igna, Oscar P ^a   Tort, Adriano B L ^a   Souza, Diogo O ^a   Lara, Diogo R ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Amphetamine; Catalepsy; Cinnarizine; Locomotion; Mice; MK 801; Psychosis; Schizophrenia

Indexed keywords

AMPHETAMINE; CALCIUM CHANNEL BLOCKING AGENT; CINNARIZINE; DIZOCILPINE; DOPAMINE 2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; EXTRAPYRAMIDAL SYMPTOM; MALE; MIGRAINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; VERTIGO;

AMPHETAMINE; ANIMALS; ANTIPSYCHOTIC AGENTS; CALCIUM CHANNEL BLOCKERS; CATALEPSY; CENTRAL NERVOUS SYSTEM STIMULANTS; CINNARIZINE; DIZOCILPINE MALEATE; DYSKINESIA, DRUG-INDUCED; EXCITATORY AMINO ACID ANTAGONISTS; HALOPERIDOL; HYPERKINESIS; MALE; MICE; MOTOR ACTIVITY; PSYCHOTIC DISORDERS;

EID: 22344431573     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105053284     Document Type: Article

References (27)

1. Anand A, Charney D S, Oren D A, Berman R M, Hu X S, Cappiello A, Krystal J H (2000) Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 57: 270-276
2. Brucke T, Wober C, Podreka I, Wober-Bingol C, Asenbaum S, Aull S, Wenger S, Ilieva D, Harasko-van der Meer C, Wessely P (1995) D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study. J Cereb Blood Flow Metab 15: 513-518
3. Bymaster F P, Calligaro D O, Falcone J F, Marsh R D, Moore N A, Tye N C, Seeman P, Wong D T (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14: 87-96
4. Dall'Igna O P, Da Silva A L, Dietrich M O, Hoffmann A, de Oliveira R V, Souza D O, Lara D R (2003) Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice. Psychopharmacology (Berl) 166: 258-263
5. Daniel J R, Mauro V F (1995) Extrapyramidal symptoms associated with calcium-channel blockers. Ann Pharmacother 29: 73-75
6. Eichler M E, Dubinsky J M, Tong J, Rich K M (1994) The ability of diphenylpiperazines to prevent neuronal death in dorsal root ganglion neurons in vitro after nerve growth factor deprivation and in vivo after axotomy. J Neurochem 62: 2148-2157
7. Farber N B, Jiang X P, Heinkel C, Nemmers B (2002) Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity. Mol Psychiatry 7: 726-733
8. Fernandez P M, Fernandez P J, Micheli F (1988) Aggravation of Parkinson's disease by cinnarizine. J Neurol Neurosurg Psychiatry 57: 158-159
9. Garcia Ruiz P J, Mena M A, Penafiel N, De Yebenes J G (1992) Cinnarizine-induced parkinsonism in primates. Clin Neuropharmacol 15: 152-154
10. Geyer M A, Ellenbroek B (2003) Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27: 1071-1079
11. Kapur S, Mamo D (2003) Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 27: 1081-1090
12. Kapur S, Seeman P (2001) Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 158: 360-369
13. Kariya S, Isozaki S, Masubuchi Y, Suzuki T, Narimatsu S (1995) Possible pharmacokinetic and pharmacodynamic factors affecting parkinsonism inducement by cinnarizine and flunarizine. Biochem Pharmacol 50: 1645-1650
14. Mena M A, Garcia de Yebenes M J, Tabernero C, Casarejos M J, Pardo B, Garcia de Yebenes J (1995) Effects of calcium antagonists on the dopamine system. J Clin Neuropharmacol 18: 410-426
15. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17: 2921-2927
16. Moghaddam B, Adams B W (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281: 1349-1352
17. Ninan I, Kulkarni S K (1999) Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine. Eur J Pharmacol 368: 1-7
18. O'Neill M F, Shaw G (1999) Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology (Berl) 145: 237-250
19. Ossowska G, Klenk-Majewska B, Lupina T (1994) The effect of calcium channel antagonists on the aggressive behavior in chronically stressed rats. Pol J Pharmacol 46: 403-408
20. Pianese C P, Hidalgo L O, Gonzalez R H, Madrid C E, Ponce J E, Ramirez A M, Moran L M, Arenas J E, Rubio A T, Uribe J O, Abiuso J, Hanuch E, Alegria J, Volpi C, Flaskamp R, Sanjuan A P, Gomez J M, Hernandez J, Pedraza A, Quijano D, Martinez C, Castaneda J R, Guerra O J, Valencia F G (2002) New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study. Otol Neurotol 23: 357-363
21. Rossi P, Fiermonte G, Pierelli F (2003) Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial. Funct Neurol 18: 155-159
22. Seeman P, Corbett R, Van Tol H H (1997) Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology 16: 93-110
23. Seeman P, Tallerico T (1998) Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry 3: 123-134
24. Tauscher J, Kufferle B, Asenbaum S, Tauscher-Wisniewski S, Kasper S (2002) Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol. Psychopharmacology (Berl) 162: 42-49
25. Terrian D M, Dorman R V, Gannon R L (1990) Characterization of the presynaptic calcium channels involved in glutamate exocytosis from rat hippocampal mossy fiber synaptosomes. Neurosci Lett 119: 211-214
26. Tong J X, Rich K M (1997) Diphenylpiperazines enhance regeneration after facial nerve injury. J Neurocytol 26: 339-347
27. Velly J, Grima M, Marciniak G, Spach M O, Schwartz J (1987) Effects of some antianginal and vasodilating drugs on sodium influx and on the binding of 3H-batrachotoxinin-A 20-alpha-benzoate and 3H-tetracaine. Naunyn Schmiedebergs Arch Pharmacol 335: 176-182